Veracyte | VCYT - Stock

Aktienkurs
41.71
Täglich Wechseln
0.21 0.51%
Monatlich
24.69%
Jährlich
44.78%
Q2 Prognose
37.71




Stock Veränderung Datum
Agilent USD 1.06B 34M 2025-12
Anika Therapeutics USD 22.84M 4.05M 2026-03
Arrowhead Research USD -173.08M 173.08M 2024-12
Bruker USD 1.12B 26.9M 2026-03
Heron Therapeutics USD 54.57M 2.33M 2022-12
Illumina USD 611M 47M 2026-03
Intrexon USD 287K 68K 2022-12
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Laboratory Of America USD 497.7M 37M 2026-03
Ligand Pharmaceuticals USD 13.27M 4.14M 2026-03
Myriad Genetics USD 27.9M 2.7M 2026-03
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Roche Holding CHF 7.6B 9M 2025-06
Siemens EUR 11.1B 841M 2025-12
Sonic Healthcare AUD 208.83M 3.83M 2024-06
Thermo Fisher Scientific USD 5.5B 71M 2026-03
Veracyte USD 21.42M 870K 2026-03
Waters USD 1.5B 923.63M 2026-03